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Abstract
Background: Clinical guidelines emphasize risk assessment as vital to patient selection for medical
primary intervention. However, risk assessment methods are restricted in their ability to predict
further coronary events. The most widely accepted tool in the United States is the Framingham
risk score. In these equations age is a powerful risk factor. Although the extent of coronary
atherosclerosis increases with age, there is large inter-individual variability in the rate of
development and progression of this disease. This fact limits the utility of Framingham scoring when
applied to individuals. Electron beam tomography (EBT), which measures coronary calcium,
provides a non-invasive method for assessing coronary plaque burden, thus offering the possibility
of providing a more accurate estimate of an individual's "arterial age" than from chronological age
alone.
Methods: In this paper we discuss a new and simple method for incorporating the coronary
calcium score (CCS) to modify the Framingham Risk Assessment (FRA). Using this method, a
coronary artery calcium (CAC) age equivalent is generated that replaces chronological age in
Framingham scoring.
Results and discussion: Using a percentile table of CCS scores by age group and sex, individuals
are matched to the age group whose calcium score most closely approximates their own individual
score. The original 10-year absolute risk score of a 65-year old man with a CCS of 6 based on
chronological age is 10%, whereas the modified absolute risk score based on CAC age equivalents
is 2%.
Conclusion:  Our approach of replacing chronological age with CAC age equivalents in the
Framingham equations possesses simplicity of application combined with precision. Physicians can
easily derive adjusted Framingham risk scores and prescribe intervention methods based on
patients' ten-year risks. The adjusted ten-year risks are likely to be more accurate than unadjusted
risks since they are based on coronary calcium score information. The modified FRA approach not
only may increase the predicted risk for some patients, but also may decrease the predicted risk
for others, making it a more precise adjustment than other methods.
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Background
Effective medical interventions to reduce risk for coronary
heart disease (CHD) have brought the issue of primary
prevention with drug therapies to the fore. There is grow-
ing evidence that both cholesterol-lowering drugs and
anti-platelet drugs will reduce risk for new onset CHD in
otherwise asymptomatic persons. The selection of
patients for medical intervention for primary prevention
therefore has assumed increasing importance in clinical
practice. Current clinical guidelines stress risk assessment
as the key to selection of persons for medical primary pre-
vention. Unfortunately, current risk assessment tools are
limited in their power to predict further major coronary
events. The most widely accepted tool in the United States
is the Framingham risk score. This scoring is based on
summing the risk of the major, independent risk factors.
Most investigators agree that while Framingham risk scor-
ing is useful, its predictive power is limited.
One concept that is gaining favor worldwide is that
asymptomatic patients whose risk for major coronary
events equals that of patients with established CHD
deserve preventive therapies similar to the latter. Most
patients with established CHD have a 10-year risk for
major coronary events (myocardial infarction + coronary
death) of >20%. Patients in this high-risk category gener-
ally will be treated with a cholesterol-lowering drug and
an antiplatelet drug. However, recent guidelines have
identified many persons in the "intermediate" risk range
(i.e., 10-year risk 10–20%) as potential candidates for
these agents. The National Cholesterol Education Pro-
gram (NCEP) reported that cholesterol-lowering drugs are
"cost-effective" for persons in this range in whom serum
cholesterol levels are elevated. In addition, the American
Heart Association has recently recommended that low-
dose aspirin therapy be instituted in persons whose 10-
year risk for major coronary events is ≥ 10%. For these rea-
sons, the identification of persons at "intermediate" risk
has become clinically important beyond the identifica-
tion of high-risk patients.
All of the major cardiovascular risk factors, except advanc-
ing age, are believed to be primary causes of coronary
heart disease (CHD). Strong evidence exists that these fac-
tors directly promote atherosclerosis and thus can lead to
major coronary events. Advancing age is a risk factor of a
different sort. It is well known that the likelihood of devel-
oping CHD increases with aging. The rationale for this is
clear; throughout life there is a slow but progressive accu-
mulation of atherosclerotic plaque in coronary arteries.
Thus, age as a risk factor is an indicator of population
plaque burden. Moreover, the probability of experiencing
an acute coronary event is directly proportional to the
total burden of coronary plaque [1-3].
The extent of coronary calcium in the arteries correlates
with the severity of coronary atherosclerosis, as shown by
autopsy studies and angiographic measurements [1,2,4].
Electron beam tomography (EBT), which measures coro-
nary calcium, provides a non-invasive method for assess-
ing coronary plaque burden. This offers the possibility of
providing a more accurate estimate of an individual's
"arterial age" than from chronological age alone.
An accepted method for estimating absolute risk for CHD
is to use Framingham risk equations. In these equations
age is a powerful risk factor. Although the extent of coro-
nary atherosclerosis increases with age, there is large inter-
individual variability in the rate of development and pro-
gression of this disease. This fact limits the utility of Fram-
ingham scoring when applied to individuals. The weakest
component of Framingham scoring for individuals is age.
This is because a fixed value for age does not take into
account the individual variation in accumulation of coro-
nary atherosclerosis with advancing age. Grundy [5] and
Greenland et al. [6] therefore proposed using coronary cal-
cium scores (CCS) to estimate the individual's "coronary
artery calcium (CAC) age equivalent "; as such, the accu-
racy of risk assessment could be improved by substituting
CCS for age as a risk factor in Framingham risk scoring.
The purpose of this study is to investigate a new and sim-
ple method for incorporating the CCS to modify the
Framingham Risk Assessment (FRA) on the basis of the
concept "you are as old as your arteries" [7].
Risk score calculation
Framingham risk assessment
For estimation of absolute 10-year risk for hard CHD
events (CHD death + myocardial infarction), we utilized
a point system based on the Framingham Heart Study and
updated for NCEP guidelines [8,9]. Published tables
(Tables 1 and 2) can be used for computation of Framing-
ham risk assessment (FRA) for men and women [8,9]. To
illustrate, consider the calculation of 10-year risk of expe-
riencing cardiac death or MI for a 55-year-old man who is
a non-smoker with systolic BP of 125, total cholesterol of
275 and HDL of 35. For every risk factor, points are
assigned according to the level of associated risk. Using
Framingham scoring, this patient receives 8 points for his
age, 0 points for blood pressure, 4 points for total choles-
terol, 3 points for HDL, for a total of 15 points and, from
the same table, corresponding to a 10-year risk of hard
events of 20%.
"CAC age equivalent" calculation method
In recent years, coronary calcium scores have been widely
measured in asymptomatic men and women. These scores
can be arranged in percentiles according to age and sex
[10-12]. On the basis of reported data, we developed aBMC Medical Imaging 2004, 4 http://www.biomedcentral.com/1471-2342/4/1
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method of using the coronary calcium score to generate a
CAC age equivalent [11]. By means of the available data
and interpolation between medians we created bounds
that define mutually exclusive adjusted-age categories that
are then utilized to replace chronological age in Framing-
ham scoring. Using table 3, which displays CCS scores by
age group and sex, individuals are matched to the age
group whose calcium score most closely approximates
their own individual score. Each age group comprised a 5-
year age range. In this manner, CCS is utilized to define an
individuals' CAC age equivalent (table 3); subsequently,
this CCS-determined coronary age is used in place of
chronological age in FRA.
Results
The utility of the proposed method is best displayed by
example. Consider a 65-year old man with a CCS of 6;
from table 3, a CCS of 6 for males corresponds to the 45–
49 age group (by virtue of being between 1.8, the lower
bound and 7.9, the upper bound for the age group). In
this example coronary age is lower than chronological
age. After determining the CAC age equivalent, we substi-
tute it for the chronological age and apply it to the Fram-
ingham scoring system. Chronological age, however, is
utilized for age-specific risk factors. The absolute risk for
this asymptomatic 65-year old man is calculated in Table
4. Along with his calcium score of 6, his total cholesterol
is 180, HDL is 52, systolic blood pressure is 117 without
using medications, and he does not smoke. The original
10-year absolute risk score of this individual based on
chronological age is 10%, whereas the modified absolute
risk score based on CAC age equivalents is 1%.
Conversely, a 37-year old male's age can be increased sub-
stantially if his calcium score is high. Accordingly, a 37
year old man with risk factors equivalent to those of the
previous example (TC = 180, HDL = 52, SBP = 117, non-
smoker) and calcium score of 100 has a CAC age equiva-
lent of 65–69 and has a modified absolute risk score of
20%, whereas the original absolute risk score for this indi-
vidual would be less than 1%. For instances where the
individual's CCS falls on the bound (e.g. a 57 year old
man with CCS = 7.9, or a 43 year old woman with CCS =
0) the age category closest to the chronological age should
be selected as the coronary age (i.e. 50–54 for our 57 year
old man and 40–44 for our 43 year old woman). Individ-
uals with CCS above the maximum values in tables (i.e.
men with CCS > 648, women with CCS > 148) are consid-
ered to have a CHD risk equivalent (i.e. risk of event equal
to that of established CHD) implying absolute 10-year
risk > 20%, based on NCEP guidelines [8,9]. The same
procedure applies for women.
The effect of this new method on risk stratification is
exhibited more generally for males and females, in Figures
1 and 2 respectively. The modified 10-year risk is dis-
played as a function of both CCS and the resultant CAC
age equivalent, with varying levels of risk by FRA. For both
men and women, low risk and intermediate risk by FRA
may be reclassified as high risk when incorporating this
Table 1: Framingham point system for men
Age range
Risk factor 20–34 35–39 40–44 45–49 50–54 55–59 60–64 65–69 70–74 75–79
Age - 9 - 40368 1 0 1 1 1 2 1 3
Total Cholesterol < 1 6 0 00000
160–199 4 3 2 1 0
200–239 7 5 3 1 0
240–279 9 6 4 2 1
≥ 280 1 1 8531
Smoking Nonsmoker 00000
Smoker 85311
HDL <40 2
40–49 1
50–59 0
≥ 60 -1
-Treatment status- Untreated Treated
Systolic blood 
pressure
<120 0 0
120–129 0 1
130–139 1 2
140–159 1 2
≥ 160 23
Total points < 0 0 – 45 – 6 7 8 9 1 01 11 21 31 41 51 6 ≥17
10-Year risk (%) < 1 1 2 3 4568 1 0 1 2 1 6 2 0 2 5 ≥30BMC Medical Imaging 2004, 4 http://www.biomedcentral.com/1471-2342/4/1
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new method. Reclassification can also occur in the oppo-
site direction. With sufficiently low CCS, men with high
risk by FRA may be considered of intermediate risk, and
both men and women with intermediate risk by FRA may
be reclassified as low risk.
Discussion
NCEP ATP III guidelines recommend Framingham risk
scoring in assessing absolute risk for CHD events [8,9].
Framingham scoring is used to inform clinical manage-
ment of asymptomatic patients for primary prevention. As
people age, chronological age becomes the predominant
risk factor [13]. Age as a risk factor is largely a "surrogate
marker" for atherosclerotic burden. Certainly, coronary
plaque burden accumulates progressively with age, but
rates of accumulation vary greatly from one person to
another. Thus, assigning the same number of Framing-
ham risk points to all individuals of the same chronolog-
ical age does not take into account the variation in plaque
burden at a given age. An alternate surrogate for plaque
burden is the CCS. Several studies show that amounts of
coronary calcium correlate strongly with total plaque bur-
den [14-17]. We therefore postulate that replacing chron-
ological age in Framingham equations with the calcium-
Table 2: Framingham point system for women
Age range
Risk factor 20–34 35–39 40–44 45–49 50–54 55–59 60–64 65–69 70–74 75–79
Age - 7 - 30368 1 0 1 2 1 4 1 6
Total Cholesterol < 1 6 0 00000
160–199 43211
200–239 86421
240–279 11 8532
≥ 280 1 3 1 0 742
Smoking Nonsmoker 00000
Smoker 97421
HDL <40 2
40–49 1
50–59 0
≥ 60 -1
-Treatment status- Untreated Treated
Systolic blood 
pressure
<120 0 0
120–129 1 3
130–139 2 4
140–159 3 5
≥ 160 4
Total points <9 9–12 13–14 15 16 17 18 19 20 21 22 23 24 ≥25
10-Year risk (%) < 1 1 2 3 4 5 6 8 1 11 41 72 22 7 ≥30
Table 3: CACa age equivalents as a function of coronary calcium score in men and women
Males CCS Females CCS CAC age equivalent
Lower Bound Upper Bound Lower Bound Upper Bound
0000 2 0 – 3 4
0 0.4 0 0 35–39
0.4 1.8 0 0 40–44
1.8 7.9 0 0 45–49
7.9 29 0 0.125 50–54
29 75 0.125 1.62 55–59
75 148 1.62 12.5 60–64
148 614 12.5 148 65–70
614 - 148 - >70
aCoronary artery calcium, CACBMC Medical Imaging 2004, 4 http://www.biomedcentral.com/1471-2342/4/1
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adjusted coronary age will better account for intra-indi-
vidual variability in disease progression. More accurate
estimates of plaque burden should improve risk predic-
tion, and consequently, improve selection of patients for
medical intervention in primary prevention.
Some investigators have expressed skepticism about the
utility of CCS in risk prediction and especially whether
they provide predictive power independently of the major
risk factors. What is really being questioned is whether it
is a better predictor than age as a risk factor. The claim is
Table 4: Calculation of absolute risk of a 65 year-old with a calcium score of 6.
Risk Factor Standard Framingham scoring Coronary calcium modified Framingham scoring
CAC age equivalent (from table 3) 11 3
Total Cholesterol (180 mg/dl) 1 1
HDL (52 mg/dl) 0 0
Smoking (non-smoker) 0 0
Systolic blood pressure (117 mmHg) 0 0
Total points 12 4
10-year absolute risk 10% 1%
Absolute 10-year risk for low, intermediate, and high risk 50-year-old men by CAC age equivalent adjusted age group Figure 1
Absolute 10-year risk for low, intermediate, and high risk 50-year-old men by CAC age equivalent adjusted age group.
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made that what is needed is a new Framingham Heart
Study in which CCSs are included in a prospective study
along with other major risk factors. The Framingham
Heart Study was carried out over a period of many years;
risk factors were identified and quantified at the begin-
ning and were left untreated over the duration of study.
Any prospective study that adds CCSs to the mix of predic-
tive risk factors is unlikely to be feasible since major coro-
nary risk factors can no longer be left untreated for long
periods in a study population. A current long-term pro-
gram, the Multi-Ethnic Study of Atherosclerosis is
designed to address the role of subclinical atherosclerosis
in risk prediction; this study however must evaluate the
predictive power of coronary calcium and other subclini-
cal surrogates indirectly. Findings furthermore will not be
available for many years. The purpose of our study is to
provide a means to employ estimates of subclinical
atherosclerosis in quantitative risk prediction at the
present time. It does this by linking CCS directly with
Framingham risk scoring.
There is increasing recognition that CCS has useful predic-
tive power for major coronary events. The potential for
this purpose was noted in the American Heart Associa-
tions Prevention V conference, in an American Heart
Association/American College of Cardiology report on
EBT, and in the recent NCEP ATP III report [9]. These
reports indicate that EBT is a clinical option for risk assess-
ment for evaluation of individuals to adjust absolute risk
estimates. However, none of these reports specified how
CCS information could be used for this purpose. Subse-
quently, several studies have reported the power and/or
independence of CCS in risk prediction. However, these
studies collectively do not provide a guide for integrating
CCS into absolute, quantitative risk assessment. The
Absolute 10-year risk for low, intermediate, and high risk 50-year-old women by CAC age equivalent adjusted age group Figure 2
Absolute 10-year risk for low, intermediate, and high risk 50-year-old women by CAC age equivalent adjusted age group.
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present report proposes a method to get around this
impasse.
Alternative approaches to risk assessment
Greenland et al. [6] have proposed an alternate approach
for incorporation of CCS into the Framingham Risk
Index. In this method, all individuals of intermediate risk,
defined in this report as Framingham Risk of 5–20%, and
a CCS greater than 80 are raised to the high-risk category
(> 20%). This particular CCS score pertains to only to
published data in middle-aged men whose Framingham
risk scores are in this range; it does not hold for women or
older men. The advantage of this method lies in its parsi-
mony; clinicians could easily be expected to apply this
simple evaluation for middle-aged men with two or more
risk factors.
However, this simplicity may come at a cost, as it does not
take into account much available information. Because
coronary calcium varies greatly with age and is impacted
by gender, a one-size-fits-all cut point will be limited in
effectiveness. Additionally, this method fails to consider
the information garnered from a negative scan; those indi-
viduals with intermediate to high risk by FRA and little to
no subclinical disease by EBT are not reassigned to lower
risk categories. Because ATP III guidelines draw a distinc-
tion between low risk and intermediate risk individuals
for treatment, the unidirectional risk adjustment has real
clinical implications [8,9].
Our proposed method is more quantitative and based on
a continuum of risk. This more linear relation may possess
greater accuracy in representing risk. While more complex
than the approach suggested by Greenland et al. [6], use of
calcium-adjusted coronary age can be easily incorporated
into Framingham risk scoring and NCEP guidelines.
Similarly, the proposed method may add information
missing from the current guidelines in ATP III [9]. These
guidelines suggest interchangeability between FRA and
count of risk factors. They suggest that few individuals
with 0–1 risk factors will be in the higher risk categories,
i.e., 10-year risk ≥ 10%. Such lower risk individuals thus
are not good candidates for EBT screening. However, men
older than 70 have a baseline Framingham 10-year risk of
10%; assessing CAC age equivalent in these individuals
may be of particular utility for risk stratification.
Potential advantages of age adjustment by coronary 
calcium
Our approach of replacing chronological age with CAC
age equivalents in the Framingham equations possesses
simplicity of application combined with precision. Physi-
cians can easily derive adjusted Framingham risk scores
and prescribe intervention methods based on patients'
ten-year risks. The adjusted ten-year risks are likely to be
more accurate than unadjusted risks since they are based
on coronary calcium score information. The modified
FRA approach increases the risk for some patients and
decreases the risk for others, making it a more precise
adjustment than other methods.
Implications of the modified risk assessment approach in 
differing risk groups
Modifying risk assessment methods has important impli-
cations for patient management as well as for cost effec-
tiveness of treatments. In the low risk categories, it is clear
that CAC age equivalent is very close to chronological age,
as indicated by the high concordance between Framing-
ham and our modified Framingham risk scores. This may
imply that EBT is not warranted for routine risk assess-
ment in individuals with low Framingham risk scores. In
the high-risk category (10-year risk > 20%), CAC age
equivalent may only reclassify a small percentage of indi-
viduals. This implies that EBT may be more effective in
this group for monitoring progression of disease and
effectiveness of therapy [18-25].
Use of calcium-adjusted coronary age in place of chrono-
logical age will have the greatest impact on persons deter-
mined to be in the 10-year risk range of 10–20% by
standard Framingham risk scoring. The approach
employed assumes that for any Framingham risk score
low levels of coronary artery calcium justify reducing a
person's risk estimate whereas high levels warrant raising
the risk. In the current subjects with 10–20% risk, our
method results in a high rate of reclassification of patients,
both to higher and lower risk categories. This group of
subjects thus should benefit the most from EBT. Evidence
of advanced subclinical disease otherwise not detected
may identify individuals who are not receiving appropri-
ate treatment. For others, EBT may identify patients in
whom aggressive medical therapy is unneeded and not
cost-effective.
Limitations of age adjustment
A limitation of this study is that the data utilized to gener-
ate the coronary age equivalent algorithm comes from
patients who may not be representative of the general
population [11]. These individuals were likely mostly self-
referred and were recruited from seven centers located
across the US. Unlike the Framingham cohort, this sample
was clinic based rather than population based. Neverthe-
less, comparison of major risk factors between the Fram-
ingham cohort and a sample of the calcium screening
cohort suggests a similar risk level [26,27]. If other base-
line factors related to development of CAC are unequally
distributed in the study populations, the age-CCS relation
presented herein may require modification. The precise
relation between CCS and Framingham points is anBMC Medical Imaging 2004, 4 http://www.biomedcentral.com/1471-2342/4/1
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aspect of the described method that must be validated in
appropriate settings. However, the mostly asymptomatic
nature, the geographical diversity and large size of the
study sample (59,289 patients), may allow for valid com-
parisons. Moreover, this group is a good representation of
the individuals that pursue calcium screening.
Notably, outcome data were not available for this study,
so the efficacy of this method of assessment cannot be
evaluated presently. We strongly encourage investigators
with access to data including Framingham risk factors,
CCS and CHD outcomes to do so. Our method fails to
adequately take into account elevations of risk in patients
with marked elevation of coronary calcium scores since
age scores are available up to age 75 in the FRA. Longitu-
dinal studies that include both measurements of coronary
calcium scores and have outcomes of CHD events are
needed to better evaluate the different methods of adjust-
ing age in the Framingham equations.
Conclusion
Use of CAC age equivalent has the potential to improve
global risk prediction for primary prevention of CHD.
CCS may be effectively used by replacing age as a risk fac-
tor in Framingham risk equations; such scores are a more
direct measure of coronary plaque burden than chrono-
logical age. Use of the modified Framingham risk score
should make it possible to integrate CCS with other risk
factors to obtain quantitative risk estimates. The modified
FRA method may not only improve the efficacy of inter-
vention, but may also do so without greatly increasing the
cost of preventive medical therapies. However, coronary
calcium measurements need not be done routinely in risk
assessment. They appear to be indicated only for those
individuals whose Framingham risk scores are ≥ 10%.
This approach will reduce the number of subjects who will
require assessment of subclinical atherosclerosis, and it
will provide more precise information for cost-effective
and efficacious intervention with drug therapy. We
encourage investigators with access to data including
Framingham risk factors, CCS and CHD outcomes to eval-
uate this method to determine if its use in practice proves
as effective as in theory.
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